Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. Financials
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 1 187 9051 148 922845 2861 434 322--
Entreprise Value (EV)1 1 140 4271 131 107797 9261 363 2381 529 0571 476 416
P/E ratio 55,0x43,1x22,5x49,4x25,8x22,3x
Yield 0,40%0,57%0,28%1,25%0,66%0,75%
Capitalization / Revenue 4,48x3,95x2,57x4,28x4,36x4,00x
EV / Revenue 4,31x3,89x2,43x4,07x4,11x3,64x
EV / EBITDA 20,3x17,9x11,4x16,1x16,4x14,1x
Price to Book 3,12x2,77x1,87x3,09x3,14x2,81x
Nbr of stocks (in thousands) 2 399 3232 399 3352 399 3352 399 335--
Reference price (INR) 495479352598677677
Last update 05/25/201805/28/201905/27/202005/27/202106/03/202106/03/2021
1 INR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 264 895290 659328 375334 981372 250406 101
EBITDA1 56 08163 07669 89884 91492 974104 476
Operating profit (EBIT)1 41 08345 54349 37064 11471 70082 969
Operating Margin 15,5%15,7%15,0%19,1%19,3%20,4%
Pre-Tax Profit (EBT)1 34 79038 10250 09627 99478 45590 697
Net income1 21 61626 65437 64929 03862 85072 384
Net margin 8,16%9,17%11,5%8,67%16,9%17,8%
EPS2 9,0011,115,712,126,330,3
Dividend per Share2 2,002,751,007,504,495,07
Last update 05/25/201805/28/201905/27/202005/27/202106/03/202106/03/2021
1 INR in Million
2 INR
Estimates
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 47 47817 81447 36071 08595 533148 174
Leverage (Debt / EBITDA) -0,85x-0,28x-0,68x-0,84x-1,03x-1,42x
Free Cash Flow1 19 464-10 16450 12850 00242 65561 911
ROE (Net Profit / Equities) 7,71%9,25%8,69%6,33%12,6%13,2%
Shareholders' equity1 280 368288 069433 368458 667499 088550 341
ROA (Net Profit / Asset) 4,58%5,71%5,66%4,27%8,38%9,22%
Assets1 471 573466 880664 736679 574749 881784 705
Book Value Per Share2 159173189194216241
Cash Flow per Share2 16,39,1527,325,721,128,9
Capex1 19 60832 12815 42011 70117 93517 789
Capex / Sales 7,40%11,1%4,70%3,49%4,82%4,38%
Last update 05/25/201805/28/201905/27/202005/27/202106/03/202106/03/2021
1 INR in Million
2 INR
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (INR)
1 624 589 708 187
Capitalization (USD)
22 200 520 760
Net sales (INR)
328 375 000 000
Net sales (USD)
4 485 602 500
Number of employees
36 000
Sales / Employee (INR)
9 121 528
Sales / Employee (USD)
124 600
Free-Float
82,7%
Free-Float capitalization (INR)
1 343 282 304 001
Free-Float capitalization (USD)
18 356 368 089
Avg. Exchange 20 sessions (INR)
4 597 488 749
Avg. Exchange 20 sessions (USD)
62 801 696
Average Daily Capital Traded
0,3%
EPS & Dividend